Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C, van Geel AN, Tilanus MM, Bartels CC, Verhoog LC, Brekelmans CT, Burger CW, Niermeijer MF. Lodder LN, et al. Among authors: niermeijer mf. Breast Cancer Res Treat. 2002 May;73(2):97-112. doi: 10.1023/a:1015269620265. Breast Cancer Res Treat. 2002. PMID: 12088120
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG. Meijers-Heijboer H, et al. Among authors: niermeijer mf. N Engl J Med. 2001 Jul 19;345(3):159-64. doi: 10.1056/NEJM200107193450301. N Engl J Med. 2001. PMID: 11463009 Free article.
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
Verhoog LC, van den Ouweland AM, Berns E, van Veghel-Plandsoen MM, van Staveren IL, Wagner A, Bartels CC, Tilanus-Linthorst MM, Devilee P, Seynaeve C, Halley DJ, Niermeijer MF, Klijn JG, Meijers-Heijboer H. Verhoog LC, et al. Among authors: niermeijer mf. Eur J Cancer. 2001 Nov;37(16):2082-90. doi: 10.1016/s0959-8049(01)00244-1. Eur J Cancer. 2001. PMID: 11597388
The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
Bresser PJ, Seynaeve C, Van Gool AR, Niermeijer MF, Duivenvoorden HJ, van Dooren S, van Geel AN, Menke-Pluijmers MB, Klijn JG, Tibben A. Bresser PJ, et al. Among authors: niermeijer mf. Eur J Cancer. 2007 Jan;43(1):95-103. doi: 10.1016/j.ejca.2006.09.009. Epub 2006 Nov 13. Eur J Cancer. 2007. PMID: 17095208
Psychological impact of receiving a BRCA1/BRCA2 test result.
Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF. Lodder L, et al. Among authors: niermeijer mf. Am J Med Genet. 2001 Jan 1;98(1):15-24. Am J Med Genet. 2001. PMID: 11426450
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF. Lodder L, et al. Among authors: niermeijer mf. Eur J Hum Genet. 2001 Jul;9(7):492-500. doi: 10.1038/sj.ejhg.5200668. Eur J Hum Genet. 2001. PMID: 11464240
230 results